These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 6033236)
1. Is cervical carcinoma in situ a significant lesion? Green GH Int Surg; 1967 Jun; 47(6):511-7. PubMed ID: 6033236 [No Abstract] [Full Text] [Related]
2. Cervical cancer screening: précis and critique of a recent Canadian report. Chiavetta J; Leader SR Med J Aust; 1977 Jan 1-8; 1(1-2):23-8. PubMed ID: 840075 [No Abstract] [Full Text] [Related]
3. The therapy and follow-up of in situ and microinvasive carcinoma of the cervix. Lash AF Int Surg; 1967 Jun; 47(6):518-27. PubMed ID: 6033237 [No Abstract] [Full Text] [Related]
4. The progression of pre-invasive lesions of the cervix to invasion. Green GH N Z Med J; 1974 Oct; 80(525):279-87. PubMed ID: 4531563 [No Abstract] [Full Text] [Related]
5. Cytology screening--a program that works. MacLean MA Can Nurse; 1969 May; 65(5):40-3. PubMed ID: 5769363 [No Abstract] [Full Text] [Related]
6. [On the treatment of Ca in situ of the uterine cervix]. Svindler EA; Leibman IuIa Vopr Onkol; 1967; 13(7):39-44. PubMed ID: 5598968 [No Abstract] [Full Text] [Related]
8. The significance of cervical carcinoma in situ. Green GH Aust N Z J Obstet Gynaecol; 1966 Feb; 6(1):42-4. PubMed ID: 5218310 [No Abstract] [Full Text] [Related]
9. The changing patterns of cervix cancer. Christopherson WM CA Cancer J Clin; 1971; 21(5):283-7. PubMed ID: 4999532 [No Abstract] [Full Text] [Related]
10. Detection of cervical cancer by cytologic screening: period, 1948-1953 and 1958-1963. Tilden IL; Nishimura JK Pac Med Surg; 1966; 74(1):53-5. PubMed ID: 5904449 [No Abstract] [Full Text] [Related]
11. The significance of cervical carcinoma in situ. Green GH Am J Obstet Gynecol; 1966 Apr; 94(7):1009-22. PubMed ID: 5910357 [No Abstract] [Full Text] [Related]
12. [The significance of cytodiagnosis as a screening method in the domain of early diagnosis of cervix cancer and its early stages for the general practioner]. Bötzelen HP; Meyer K Z Allgemeinmed; 1964 Dec; 40(36):1549-51. PubMed ID: 5889485 [No Abstract] [Full Text] [Related]
13. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives. Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014 [TBL] [Abstract][Full Text] [Related]
14. False negative rate in mass screening for cervical cancer. Sato S; Mikino H; Matsunaga G; Yajima A Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728 [No Abstract] [Full Text] [Related]
15. The impact of the National Cervical Screening Programme on the presentation of cancer of the cervix in Canterbury. Simcock B; Sykes P; Laney M N Z Med J; 2001 Aug; 114(1138):378-80. PubMed ID: 11589435 [TBL] [Abstract][Full Text] [Related]
16. [Positive cytology of the cervix, its histological clarification and the following choice of treatment]. Michalzik K; Ober KG Geburtshilfe Frauenheilkd; 1966 Feb; 26(2):202-22. PubMed ID: 5982485 [No Abstract] [Full Text] [Related]
17. Two-wavelength Feulgen cytophotometry of cells exfoliated from the uterine cervix. Hrushovetz SB Acta Cytol; 1969 Oct; 13(10):583-94. PubMed ID: 4186897 [No Abstract] [Full Text] [Related]
18. [Registration of carcinoma in situ and squamous cell carcinoma of the uterine cervix in the screening area of Nijmegen from 1 January 1970 through 31 July 1982]. Klinkhamer PJ; van der Graaf Y; Vooijs GP Ned Tijdschr Geneeskd; 1984 Oct; 128(42):1979-83. PubMed ID: 6504185 [No Abstract] [Full Text] [Related]
19. The cytological diagnosis of carcinoma in situ. Ward JG J S C Med Assoc; 1966 Oct; 62(10):389-92. PubMed ID: 5232376 [No Abstract] [Full Text] [Related]
20. [Flow & image cytometry and clinical applications in cancer diagnosis]. Nishiya I; Izutsu T Rinsho Byori; 1993 Jun; Suppl 94():51-65. PubMed ID: 8361009 [No Abstract] [Full Text] [Related] [Next] [New Search]